Successful Rapid Desensitization to Ceftazidime/Avibactam in a Patient With Cystic Fibrosis and Multidrug-Resistant Pseudomonas aeruginosa Pneumonia: A Case Report
{{output}}
Ceftazidime/avibactam (CAZ-AVI) is an important therapeutic option for multidrug-resistant (MDR) Pseudomonas aeruginosa infections; however, hypersensitivity reactions may preclude its use and create significant therapeutic challenges. We report a 21-year-old ... ...